Using virtual multiteam systems to conduct a multisite randomized clinical trial in the part C early intervention system: Benefits, challenges, and lessons learned

IF 2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Contemporary clinical trials Pub Date : 2024-05-29 DOI:10.1016/j.cct.2024.107585
Brooke Ingersoll , Anthuanet Espinel , Julia Nauman , Sarabeth Broder-Fingert , Alice S. Carter , R. Christopher Sheldrick , Wendy L. Stone , Allison L. Wainer
{"title":"Using virtual multiteam systems to conduct a multisite randomized clinical trial in the part C early intervention system: Benefits, challenges, and lessons learned","authors":"Brooke Ingersoll ,&nbsp;Anthuanet Espinel ,&nbsp;Julia Nauman ,&nbsp;Sarabeth Broder-Fingert ,&nbsp;Alice S. Carter ,&nbsp;R. Christopher Sheldrick ,&nbsp;Wendy L. Stone ,&nbsp;Allison L. Wainer","doi":"10.1016/j.cct.2024.107585","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Aims</h3><p>COVID-19 necessitated a shift to virtual data collection for many research projects, providing the opportunity for novel approaches to carrying out multi-site clinical trials. Virtual multiteam systems (VMTS) are a type of team structure in which multiple geographically dispersed teams collaborate using technology-mediated communication. The article presents a case study of our use of VMTS, in response to COVID-19, to carry out a multisite randomized hybrid effectiveness-implementation trial of a caregiver-implemented intervention.</p></div><div><h3>Methods</h3><p>We describe how we modified our team structure from predominantly site-specific, co-located teams to predominantly cross-site, virtual teams. We then present examples of how we have conducted the two primary data collection activities virtually. To demonstrate the feasibility of this approach, we present participant demographic information, the percent of cross-site data collection activities, and fidelity data.</p></div><div><h3>Results</h3><p>In the first 20 months of data collection, we have enrolled 108 EI providers and 132 families, with 17% and 9% attrition respectively. The family sample is highly diverse in terms of race/ethnicity, parent education, and household income. The majority of provider training activities and roughly 50% of family assessment activities have been conducted cross-site. Fidelity is high, with no differences across site.</p></div><div><h3>Conclusions</h3><p>Our data illustrate the feasibility of using virtual teams, training, and assessment in a multisite clinical trial in the Part C system. We discuss the strengths and challenges of this approach, as well as lessons learned to facilitate the planning of future multisite randomized clinical trials which may benefit from this approach.</p></div><div><h3>Clinical Trials</h3><p><span>NCT05114538</span><svg><path></path></svg></p></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S155171442400168X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Aims

COVID-19 necessitated a shift to virtual data collection for many research projects, providing the opportunity for novel approaches to carrying out multi-site clinical trials. Virtual multiteam systems (VMTS) are a type of team structure in which multiple geographically dispersed teams collaborate using technology-mediated communication. The article presents a case study of our use of VMTS, in response to COVID-19, to carry out a multisite randomized hybrid effectiveness-implementation trial of a caregiver-implemented intervention.

Methods

We describe how we modified our team structure from predominantly site-specific, co-located teams to predominantly cross-site, virtual teams. We then present examples of how we have conducted the two primary data collection activities virtually. To demonstrate the feasibility of this approach, we present participant demographic information, the percent of cross-site data collection activities, and fidelity data.

Results

In the first 20 months of data collection, we have enrolled 108 EI providers and 132 families, with 17% and 9% attrition respectively. The family sample is highly diverse in terms of race/ethnicity, parent education, and household income. The majority of provider training activities and roughly 50% of family assessment activities have been conducted cross-site. Fidelity is high, with no differences across site.

Conclusions

Our data illustrate the feasibility of using virtual teams, training, and assessment in a multisite clinical trial in the Part C system. We discuss the strengths and challenges of this approach, as well as lessons learned to facilitate the planning of future multisite randomized clinical trials which may benefit from this approach.

Clinical Trials

NCT05114538

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在 C 部分早期干预系统中使用虚拟多站点系统开展多站点随机临床试验:收益、挑战和经验教训。
背景/目的:COVID-19 使许多研究项目必须转向虚拟数据收集,为开展多站点临床试验提供了新方法。虚拟多团队系统(VMTS)是一种团队结构,在这种结构中,多个分散在不同地理位置的团队利用以技术为媒介的通信进行协作。本文介绍了我们使用虚拟多团队系统的案例研究,该系统响应 COVID-19,对以护理人员为媒介的干预措施进行多站点随机混合有效性实施试验:我们介绍了如何将团队结构从主要针对特定地点的同地团队调整为主要针对跨地点的虚拟团队。然后,我们将举例说明我们是如何通过虚拟方式开展两项主要数据收集活动的。为了证明这种方法的可行性,我们介绍了参与者的人口统计信息、跨站点数据收集活动的百分比以及忠实度数据:在数据收集的前 20 个月中,我们共招募了 108 名幼儿保育员和 132 个家庭,流失率分别为 17% 和 9%。家庭样本在种族/民族、父母教育程度和家庭收入方面高度多样化。大多数托养者培训活动和大约 50%的家庭评估活动都是跨地区进行的。保真度很高,不同地点之间没有差异:我们的数据说明了在 C 部分系统的多站点临床试验中使用虚拟团队、培训和评估的可行性。我们讨论了这种方法的优势和挑战,并总结了经验教训,以促进未来多站点随机临床试验的规划,这些试验可能会受益于这种方法:NCT05114538。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
4.50%
发文量
281
审稿时长
44 days
期刊介绍: Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.
期刊最新文献
Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine The clinical and cost effectiveness of internet-delivered self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): Study protocol for a randomised controlled trial with ethnically diverse family carers Editorial Board Enhancing clinical drug trial monitoring with blockchain technology Methods to characterize lactate turnover in aging and Alzheimer's disease; The LEAN study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1